Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 47 articles:
HTML format
Text format



Single Articles


    February 2017
  1. PAN Q, Meng L, Ye J, Wei X, et al
    Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT).
    Cancer Lett. 2017 Feb 2. pii: S0304-3835(17)30081.
    PubMed     Text format     Abstract available


    January 2017
  2. LIU R, Tang J, Ding C, Liang W, et al
    The depletion of ATM inhibits colon cancer proliferation and migration via B56gamma2-mediated Chk1/p53/CD44 cascades.
    Cancer Lett. 2017 Jan 13. pii: S0304-3835(17)30024.
    PubMed     Text format     Abstract available


  3. XIE R, Wang J, Tang W, Li Y, et al
    Rufy3 promotes metastasis through epithelial-mesenchymal transition in colorectal cancer.
    Cancer Lett. 2017 Jan 12. pii: S0304-3835(17)30015.
    PubMed     Text format     Abstract available


    December 2016
  4. LI Y, Oliver PG, Lu W, Pathak V, et al
    SRI36160 is a specific inhibitor of Wnt/beta-catenin signaling in human pancreatic and colorectal cancer cells.
    Cancer Lett. 2016 Dec 30. pii: S0304-3835(16)30800.
    PubMed     Text format     Abstract available


  5. CERDA MB, Lloyd R, Batalla M, Giannoni F, et al
    Silencing peroxiredoxin-2 sensitizes human colorectal cancer cells to ionizing radiation and oxaliplatin.
    Cancer Lett. 2016;388:312-319.
    PubMed     Text format     Abstract available


  6. HUANG GL, Zhang W, Ren HY, Zhou P, et al
    Oncogenic retinoic acid receptor alpha promotes human colorectal cancer growth through simultaneously regulating p21 transcription and GSK3beta/beta-catenin signaling.
    Cancer Lett. 2016 Dec 5. pii: S0304-3835(16)30743.
    PubMed     Text format     Abstract available


  7. WANG FF, Zhang XJ, Yan YR, Zhu XH, et al
    FBX8 is a metastasis suppressor downstream of miR-223 and targeting mTOR for degradation in colorectal cancer.
    Cancer Lett. 2016 Dec 1. pii: S0304-3835(16)30732.
    PubMed     Text format     Abstract available


    November 2016
  8. DONG R, Gong Y, Meng W, Yuan M, et al
    The involvement of M2 macrophage polarization inhibition in fenretinide-mediated chemopreventive effects on colon cancer.
    Cancer Lett. 2016 Nov 30. pii: S0304-3835(16)30717.
    PubMed     Text format     Abstract available


  9. YAN C, Luo L, Guo CY, Goto S, et al
    Doxorubicin-induced mitophagy contributes to drug resistance in cancer stem cells from HCT8 human colorectal cancer cells.
    Cancer Lett. 2016 Nov 30. pii: S0304-3835(16)30706.
    PubMed     Text format     Abstract available


  10. ZHANG WJ, Li Y, Wei MN, Chen Y, et al
    Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer.
    Cancer Lett. 2016 Nov 15. pii: S0304-3835(16)30697.
    PubMed     Text format     Abstract available


  11. ABU LILA AS, Moriyoshi N, Fukushima M, Huang CL, et al
    Metronomic S-1 dosing and thymidylate synthase silencing have synergistic antitumor efficacy in a colorectal cancer xenograft model.
    Cancer Lett. 2016 Nov 9. pii: S0304-3835(16)30683.
    PubMed     Text format     Abstract available


  12. JO YK, Roh SA, Lee H, Park NY, et al
    Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells.
    Cancer Lett. 2016;385:21-27.
    PubMed     Text format     Abstract available


  13. ZHOU P, Xiao N, Wang J, Wang Z, et al
    SMC1A recruits tumor-associated-fibroblasts (TAFs) and promotes colorectal cancer metastasis.
    Cancer Lett. 2016 Nov 4. pii: S0304-3835(16)30672.
    PubMed     Text format     Abstract available


  14. PLATET N, Hinkel I, Richert L, Murdamoothoo D, et al
    The tumor suppressor CDX2 opposes pro-metastatic biomechanical modifications of colon cancer cells through organization of the actin cytoskeleton.
    Cancer Lett. 2016 Nov 2. pii: S0304-3835(16)30671.
    PubMed     Text format     Abstract available


    October 2016
  15. DE MIGUEL D, Gallego Lleyda A, Ayuso JM, Pejenaute-Ochoa D, et al
    High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer.
    Cancer Lett. 2016 Oct 8. pii: S0304-3835(16)30612.
    PubMed     Text format     Abstract available


  16. DU J, Wang Y, Chen D, Ji G, et al
    BAY61-3606 potentiates the anti-tumor effects of TRAIL against colon cancer through up-regulating DR4 and down-regulating NF-kappaB.
    Cancer Lett. 2016 Oct 6. pii: S0304-3835(16)30609.
    PubMed     Text format     Abstract available


  17. WEN C, Chen J, Zhang D, Wang H, et al
    Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
    Cancer Lett. 2016 Oct 3. pii: S0304-3835(16)30549.
    PubMed     Text format     Abstract available


    September 2016
  18. MOLCK C, Ryall J, Failla LM, Coates JL, et al
    The A2b adenosine receptor antagonist PSB-603 promotes oxidative phosphorylation and ROS production in colorectal cancer cells via adenosine receptor-independent mechanism.
    Cancer Lett. 2016 Sep 28. pii: S0304-3835(16)30560.
    PubMed     Text format     Abstract available


    August 2016
  19. HU S, Dai H, Li T, Tang Y, et al
    Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancer.
    Cancer Lett. 2016 Aug 26. pii: S0304-3835(16)30497.
    PubMed     Text format     Abstract available


  20. WANG R, Kang Y, Lohr CV, Fischer KA, et al
    Reciprocal regulation of BMF and BIRC5 (Survivin) linked to Eomes overexpression in colorectal cancer.
    Cancer Lett. 2016;381:341-348.
    PubMed     Text format     Abstract available


  21. ZHANG X, Chen Y, Hao L, Hou A, et al
    Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of putrescine.
    Cancer Lett. 2016 Aug 8. pii: S0304-3835(16)30461.
    PubMed     Text format     Abstract available


    July 2016
  22. KONG J, Sun W, Li C, Wan L, et al
    Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6.
    Cancer Lett. 2016;380:476-484.
    PubMed     Text format     Abstract available


  23. OU B, Zhao J, Guan S, Wangpu X, et al
    Plk2 promotes tumor growth and inhibits apoptosis by targeting Fbxw7/Cyclin E in colorectal cancer.
    Cancer Lett. 2016 Jul 13. pii: S0304-3835(16)30398.
    PubMed     Text format     Abstract available


    June 2016
  24. TANABE A, Tanikawa K, Tsunetomi M, Takai K, et al
    RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1alpha mRNA is translated.
    Cancer Lett. 2016;376:34-42.
    PubMed     Text format     Abstract available


  25. YOSHII Y, Furukawa T, Matsumoto H, Yoshimoto M, et al
    (64)Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133(+) cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite.
    Cancer Lett. 2016;376:74-82.
    PubMed     Text format     Abstract available


  26. LU YX, Ju HQ, Wang F, Chen LZ, et al
    Inhibition of the NF-kappaB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
    Cancer Lett. 2016 Jun 17. pii: S0304-3835(16)30374.
    PubMed     Text format     Abstract available


    May 2016
  27. KUO CT, Lee WS
    Progesterone receptor activation is required for folic acid-induced anti-proliferation in colorectal cancer cell lines.
    Cancer Lett. 2016;378:104-110.
    PubMed     Text format     Abstract available


    April 2016
  28. MA H, Pan JS, Jin LX, Wu J, et al
    Microrna-17~92 inhibits colorectal cancer progression by targeting angiogenesis.
    Cancer Lett. 2016 Apr 11. pii: S0304-3835(16)30242.
    PubMed     Text format     Abstract available


  29. MORAD SA, Bridges LC, Almeida Larrea AD, Mayen AL, et al
    Short-chain ceramides depress integrin cell surface expression and function in colorectal cancer cells.
    Cancer Lett. 2016 Apr 1. pii: S0304-3835(16)30210.
    PubMed     Text format     Abstract available


    March 2016
  30. ZHENG K, Zhou X, Yu J, Li Q, et al
    Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/beta-catenin signaling pathway.
    Cancer Lett. 2016 Mar 29. pii: S0304-3835(16)30174.
    PubMed     Text format     Abstract available


  31. ZHANG Z, Zhou C, Chang Y, Zhang Z, et al
    Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/beta-catenin pathway to promote growth and metastasis in colorectal cancer.
    Cancer Lett. 2016 Mar 21. pii: S0304-3835(16)30172.
    PubMed     Text format     Abstract available


  32. QIN X, Wang X, Liu F, Morris LE, et al
    Gankyrin activates mTORC1 signaling by accelerating TSC2 degradation in colorectal cancer.
    Cancer Lett. 2016 Mar 11. pii: S0304-3835(16)30161.
    PubMed     Text format     Abstract available


  33. CHENG F, Su L, Yao C, Liu L, et al
    SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression.
    Cancer Lett. 2016 Mar 11. pii: S0304-3835(16)30148.
    PubMed     Text format     Abstract available


  34. REN W, Shen S, Sun Z, Shu P, et al
    Jak-STAT3 pathway triggers DICER1 for proteasomal degradation by ubiquitin ligase complex of CUL4A to promote colon cancer development.
    Cancer Lett. 2016 Mar 7. pii: S0304-3835(16)30133.
    PubMed     Text format     Abstract available


    February 2016
  35. HUSSAIN A, Qazi AK, Mupparapu N, Guru SK, et al
    Modulation of glycolysis and lipogenesis by novel PI3K selective molecule represses tumor angiogenesis and decreases colorectal cancer growth.
    Cancer Lett. 2016 Feb 23. pii: S0304-3835(16)30098.
    PubMed     Text format     Abstract available


  36. SORET C, Martin E, Duluc I, Dantzer F, et al
    Distinct mechanisms for opposite functions of homeoproteins cdx2 and HoxB7 in double-strand break DNA repair in colon cancer cells.
    Cancer Lett. 2016 Feb 19. pii: S0304-3835(16)30082.
    PubMed     Text format     Abstract available


  37. KRISHN SR, Kaur S, Smith LM, Johansson SL, et al
    Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.
    Cancer Lett. 2016 Feb 16. pii: S0304-3835(16)30070.
    PubMed     Text format     Abstract available


  38. AMBERGER A, Deutschmann AJ, Traunfellner P, Moser P, et al
    17beta-hydroxysteroid dehydrogenase type 10 predicts survival of patients with colorectal cancer and affects mitochondrial DNA content.
    Cancer Lett. 2016 Feb 13. pii: S0304-3835(16)30065.
    PubMed     Text format     Abstract available


  39. OH BY, Hong HK, Lee WY, Cho YB, et al
    Animal models of colorectal cancer with liver metastasis.
    Cancer Lett. 2016 Feb 2. pii: S0304-3835(16)30020.
    PubMed     Text format     Abstract available


  40. RAJITHA B, Belalcazar A, Nagaraju GP, Shaib WL, et al
    Inhibition of NF-kappaB translocation by curcumin analogs induces G0/G1 arrest and downregulates thymidylate synthase in colorectal cancer.
    Cancer Lett. 2016 Feb 2. pii: S0304-3835(16)30042.
    PubMed     Text format     Abstract available


    January 2016
  41. ZHANG F, Luo Y, Shao Z, Xu L, et al
    MicroRNA-187, a downstream effector of TGFbeta pathway, suppresses Smad-mediated epithelial-mesenchymal transition in colorectal cancer.
    Cancer Lett. 2016 Jan 25. pii: S0304-3835(16)30007.
    PubMed     Text format     Abstract available


  42. JING Z, Sui X, Yao J, Xie J, et al
    SKF-96365 activates cytoprotective autophagy to delay apoptosis in colorectal cancer cells through inhibition of the calcium/CaMKIIgamma/AKT-mediated pathway.
    Cancer Lett. 2016 Jan 20. pii: S0304-3835(16)00018.
    PubMed     Text format     Abstract available


    December 2015
  43. DECLERCQ V, McMurray DN, Chapkin RS
    Obesity promotes colonic stem cell expansion during cancer initiation.
    Cancer Lett. 2015;369:336-43.
    PubMed     Text format     Abstract available


  44. HENRIQUES AF, Barros P, Moyer MP, Matos P, et al
    Expression of tumor-related Rac1b antagonizes B-Raf-induced senescence in colorectal cells.
    Cancer Lett. 2015;369:368-75.
    PubMed     Text format     Abstract available


  45. WILLIAMS C, DiLeo A, Niv Y, Gustafsson JA, et al
    Estrogen receptor beta as target for colorectal cancer prevention.
    Cancer Lett. 2015 Dec 18. pii: S0304-3835(15)00748.
    PubMed     Text format     Abstract available


  46. DUBASH TD, Hoffmann CM, Oppel F, Giessler KM, et al
    Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cells.
    Cancer Lett. 2015 Dec 8. pii: S0304-3835(15)00727.
    PubMed     Text format     Abstract available


    October 2015
  47. RONNEKLEIV-KELLY SM, Nukaya M, Diaz-Diaz CJ, Megna BW, et al
    Aryl hydrocarbon receptor-dependent apoptotic cell death induced by the flavonoid chrysin in human colorectal cancer cells.
    Cancer Lett. 2015 Oct 26. pii: S0304-3835(15)00645.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: